v3.26.3
Note 16 - Geographic and Segment Information
9 Months Ended
Sep. 30, 2026
Notes to Financial Statements  
Segment Reporting [Text Block]

Note 16. Geographic and Segment Information

 

Geographic Information

 

All our long-lived assets, composed of property and equipment, net by location, were held in the U.S. All our revenue from external customers was generated in the U.S.

 

Segment Information

 

Our Products segment measures of profit and loss is consolidated loss from operations, and its measure of total assets is consolidated total assets. Our CODM uses loss from operations predominantly in the annual budget and forecasting process to monitor variances in budget versus actual results along with consolidated total assets to determine resource allocation. Segment revenue from external customers, significant segment non-cash items, and other significant segment expense categories included within the measure of profit and loss and provided to our CODM were all based on their consolidated amounts. During the three and nine months ended September 30, 2026 and 2025, these items were as follows:

 

  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 

(in thousands)

 

2026

  

2025

  

2026

  

2025

 

Segment revenue from external customers

 $56  $15  $161  $123 

Segment operating expenses:

                

Cost of revenue

  16   —   52   20 

Research and development:

                

CNM-Au8:

                

Amyotrophic lateral sclerosis

  1,509   1,775   3,045   4,586 

Multiple sclerosis

  45   41   152   230 

Regulatory activities

  483   75   1,050   335 

General/preclinical/nonclinical

  17   (108)  138   (26)

Facilities

  423   436   1,207   1,241 

Depreciation

  333   337   1,007   1,012 

Manufacturing

  776   363   931   633 

Research

  3   1   13   8 

Equipment

  40   30   124   58 

Maintenance

  69   53   118   117 

Information technology

  102   68   245   187 

Personnel

  2,201   1,945   6,412   6,205 

Stock-based compensation

  524   754   1,764   2,300 

Grant revenue as a reduction of research and development expense

  (2,107)  (2,270)  (8,021)  (8,495)

Other segment items ‒ Research and development(1)

  29   13   62   117 

General and administrative:

                

Insurance

  158   182   486   544 

Legal

  37   70   232   393 

Finance and accounting

  226   270   714   800 

Public and investor relations

  80   63   282   293 

Facilities

  31   29   94   90 

Depreciation

  16   28   50   123 

Information technology

  38   27   100   123 

Personnel

  837   569   2,254   2,189 

Stock-based compensation

  555   949   1,667   2,717 

Grant revenue as a reduction of general and administrative expense

  (116)  (130)  (445)  (358)

Other segment items ‒ General and administrative(2)

  78   93   183   269 

Segment loss from operations

  (6,347)  (5,648)  (13,755)  (15,588)
                 

Reconciliation of segment loss from operations:

                

Adjustments and reconciling items

  —   —   —   — 

Consolidated loss from operations

 $(6,347) $(5,648) $(13,755) $(15,588)

 

(1)

Includes expenses for travel, meals, dues, subscriptions, continuing education, and other miscellaneous expenses.

 

 (2)

Includes expenses for travel, meals, dues, subscriptions, continuing education, lobbying, banking fees, postage, and other office and miscellaneous expenses.

 

Our revenue during the three and nine months ended September 30, 2026 and 2025 was predominantly with a single customer, 4Life, through our Amended 4Life Agreements (see Note 15). A reconciliation of the total of the Products segment loss from operations to consolidated net income (loss) before income taxes for the three and nine months ended September 30, 2026 and 2025 was as follows:

 

  

Three Months Ended September 30,

  

Nine Months Ended September 30,

 

(in thousands)

 

2026

  

2025

  

2026

  

2025

 

Segment loss from operations

 $(6,347) $(5,648) $(13,755) $(15,588)

Total other income (expense), net(1)

  10,262   (3,129)  (3,845)  (1,359)

Net income (loss) before income taxes

 $3,915  $(8,777) $(17,600) $(16,947)

 

(1)

Represents consolidated total other income (expense), net, as reported on the condensed consolidated statements of operations and comprehensive income (loss).

 

Products segment assets exclude corporate assets, such as cash, restricted cash, and corporate facilities. Total assets as of September 30, 2026 and  December 31, 2025 were as follows:

 

  

September 30,

  

December 31,

 

(in thousands)

 

2026

  

2025

 

Total assets:

        

Products

 $12,206  $12,828 

Corporate

  9,951   5,303 

Consolidated

 $22,157  $18,131 

 

Additions to long-lived assets during the nine months ended September 30, 2026 and 2025 were as follows:

 

  

Nine Months Ended September 30,

 

(in thousands)

 

2026

  

2025

 

Products

 $52  $11 

Corporate

  —   — 

Consolidated

 $52  $11